Literature DB >> 10927637

Increased magnitude of relaxation to oestrogen in aorta from oestrogen receptor beta knock-out mice.

B O Nilsson1, E Ekblad, T Heine, J A Gustafsson.   

Abstract

Micromolar concentrations of the biologically active oestrogen 17beta-oestradiol reduce agonist-induced force in vascular preparations through an unidentified mechanism. The aim of the present study was to investigate the importance of oestrogen receptor beta (ERbeta) for oestrogen-induced vascular relaxation. 17beta-oestradiol was added to aortic rings from ERbeta knock-out (-/-) and wild-type (+/+) mice precontracted with noradrenaline. 17beta-oestradiol caused a concentration-dependent (1-100 microM) relaxation of aortic rings from both -/- and +/+ animals of both sexes. Rings from male and female -/- mice were more sensitive to 17beta-oestradiol than those from +/+ mice. Medial thickness, determined by computerized image analysis, was similar in rings from -/- and +/+ animals. Endothelium, as determined by immuno-cytochemistry, was present in -/- and +/+ aorta. Maximal noradrenaline evoked force and sensitivity to noradrenaline were similar in both groups. In summary ERbeta modulates vascular relaxation to microM concentrations of oestrogen; lack of ERbeta renders the vascular wall supersensitive to 17beta-oestradiol. Lack of ERbeta caused no change in vascular wall morphology suggesting that this ER subtype is not involved in vascular structure development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10927637     DOI: 10.1677/joe.0.166r005

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

1.  Acute effects of oestrogen receptor subtype-specific agonists on vascular contractility.

Authors:  Sandra Montgomery; Linda Shaw; Nick Pantelides; Michael Taggart; Clare Austin
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 2.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

Review 3.  Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen.

Authors:  Sarah H Lindsey; Mark C Chappell
Journal:  Gend Med       Date:  2011-12

4.  The oestrogen receptor beta contributes to sex related differences in endothelial function of murine small arteries via EDHF.

Authors:  Leonid Luksha; Lucilla Poston; Jan-Ake Gustafsson; Kjell Hultenby; Karolina Kublickiene
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

5.  Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat.

Authors:  Sarah H Lindsey; Kyle A Carver; Eric R Prossnitz; Mark C Chappell
Journal:  J Cardiovasc Pharmacol       Date:  2011-05       Impact factor: 3.105

6.  Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.

Authors:  Graciliano R A do Nascimento; Yaskara V R Barros; Amanda K Wells; Raouf A Khalil
Journal:  Curr Hypertens Rev       Date:  2009-11

Review 7.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats.

Authors:  Danielle K Lewis; Adam B Johnson; Shannon Stohlgren; Ashley Harms; Farida Sohrabji
Journal:  J Neuroimmunol       Date:  2008-03-06       Impact factor: 3.478

9.  Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.

Authors:  Reagan L Ross; Michelle R Serock; Raouf A Khalil
Journal:  Curr Cardiol Rev       Date:  2008-11

Review 10.  Approaching Sex Differences in Cardiovascular Non-Coding RNA Research.

Authors:  Amela Jusic; Antonio Salgado-Somoza; Ana B Paes; Francesca Maria Stefanizzi; Núria Martínez-Alarcón; Florence Pinet; Fabio Martelli; Yvan Devaux; Emma Louise Robinson; Susana Novella
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.